Valerio Therapeutics

C4X

Company Profile

  • Business description

    Valerio Therapeutics is a clinical-stage biotechnology company designing and developing novel oncology drugs targeting tumor DNA repair functions. Its therapeutic strategy focuses on fighting tumor resistance to treatments, which poses ever-greater therapeutic challenges, especially in aggressive or rare cancers. its approach is based upon unique mechanisms of action on DNA Damage Response. The company focuses on bringing first-in-class and disruptive compounds from preclinical research to proof-of-concept in man in cancer indications with high unmet needs.

  • Contact

    49 Boulevard du General
    Martial Valin
    Paris75015
    FRA

    T: +33 145587600

    https://www.valeriotx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    38

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,746.8011.10-0.13%
CAC 407,656.1227.61-0.36%
DAX 4023,317.81116.84-0.50%
Dow JONES (US)42,171.6644.14-0.10%
FTSE 1008,843.479.440.11%
HKSE23,287.28423.41-1.79%
NASDAQ19,546.2725.180.13%
Nikkei 22538,543.28341.87-0.88%
NZX 50 Index12,569.0558.27-0.46%
S&P 5005,980.871.85-0.03%
S&P/ASX 2008,528.802.40-0.03%
SSE Composite Index3,365.0223.79-0.70%

Market Movers